- $1.18bn
- $1.13bn
- $249.46m
Brief: Model N Reports Q1 Non-GAAP Earnings Per Share $0.12
U.S. RESEARCH ROUNDUP- Ameren, Miragen Therapeutics, Synopsys
NYSE ORDER IMBALANCE 82691.0 SHARES ON BUY SIDE
Brief: Model N Announces Fourth Quarter And Fiscal Year 2019 Financial Results
NYSE ORDER IMBALANCE 63750.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 70815.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 70333.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 60372.0 SHARES ON BUY SIDE
Brief: Model N Reports Q3 2019 Financial Results
Brief: Model N Q2 GAAP Loss Per Share $0.18
Brief: Model N Welcomes Scott Reese As New Board Member
Brief: Model N Announces New Chief Revenue Officer
Brief: Model N Reports Q1 Loss Per Share Of $0.15
Brief: Model N Appoints Jason Blessing As CEO
Brief: Model N Inc Reports Q4 GAAP Loss Per Share of $0.12
Brief: Model N Q4 Non-Gaap Earnings Per Share $0.06
Brief: Model N Announces Third Quarter Of Fiscal Year 2018 Financial Results
NYSE ORDER IMBALANCE 65800.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 98300.0 SHARES ON SELL SIDE